Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $223.60 million. The enterprise value is -$46.94 million.
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 19.72 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Current Share Class | 19.72M |
| Shares Outstanding | 19.72M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | -33.05% |
| Owned by Insiders (%) | 2.76% |
| Owned by Institutions (%) | 105.04% |
| Float | 19.17M |
Valuation Ratios
The trailing PE ratio is 4.93.
| PE Ratio | 4.93 |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| Forward PS | 118.81 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | 2.11 |
| P/OCF Ratio | 2.08 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.45, with a Debt / Equity ratio of 0.06.
| Current Ratio | 15.45 |
| Quick Ratio | 15.10 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.90% and return on invested capital (ROIC) is 222.22%.
| Return on Equity (ROE) | 19.90% |
| Return on Assets (ROA) | 9.25% |
| Return on Invested Capital (ROIC) | 222.22% |
| Return on Capital Employed (ROCE) | 22.22% |
| Weighted Average Cost of Capital (WACC) | 8.56% |
| Revenue Per Employee | $3.13M |
| Profits Per Employee | $1.12M |
| Employee Count | 78 |
| Asset Turnover | 0.51 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KROS has paid $4.88 million in taxes.
| Income Tax | 4.88M |
| Effective Tax Rate | 5.31% |
Stock Price Statistics
The stock price has decreased by -0.92% in the last 52 weeks. The beta is 0.90, so KROS's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -0.92% |
| 50-Day Moving Average | 15.38 |
| 200-Day Moving Average | 15.86 |
| Relative Strength Index (RSI) | 32.19 |
| Average Volume (20 Days) | 583,012 |
Short Selling Information
The latest short interest is 2.03 million, so 10.30% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 10.30% |
| Short % of Float | 10.59% |
| Short Ratio (days to cover) | 6.98 |
Income Statement
In the last 12 months, KROS had revenue of $244.06 million and earned $87.01 million in profits. Earnings per share was $2.30.
| Revenue | 244.06M |
| Gross Profit | 116.92M |
| Operating Income | 70.57M |
| Pretax Income | 91.90M |
| Net Income | 87.01M |
| EBITDA | 72.08M |
| EBIT | 70.57M |
| Earnings Per Share (EPS) | $2.30 |
Full Income StatementBalance Sheet
The company has $287.42 million in cash and $16.88 million in debt, with a net cash position of $270.53 million or $13.72 per share.
| Cash & Cash Equivalents | 287.42M |
| Total Debt | 16.88M |
| Net Cash | 270.53M |
| Net Cash Per Share | $13.72 |
| Equity (Book Value) | 303.13M |
| Book Value Per Share | 15.51 |
| Working Capital | 295.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $107.51 million and capital expenditures -$1.55 million, giving a free cash flow of $105.95 million.
| Operating Cash Flow | 107.51M |
| Capital Expenditures | -1.55M |
| Depreciation & Amortization | 1.51M |
| Net Borrowing | n/a |
| Free Cash Flow | 105.95M |
| FCF Per Share | $5.37 |
Full Cash Flow StatementMargins
Gross margin is 47.91%, with operating and profit margins of 28.91% and 35.65%.
| Gross Margin | 47.91% |
| Operating Margin | 28.91% |
| Pretax Margin | 37.65% |
| Profit Margin | 35.65% |
| EBITDA Margin | 29.53% |
| EBIT Margin | 28.91% |
| FCF Margin | 43.41% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.13% |
| Shareholder Yield | -1.13% |
| Earnings Yield | 38.92% |
| FCF Yield | 47.39% |
Analyst Forecast
The average price target for KROS is $22.25, which is 96.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.25 |
| Price Target Difference | 96.21% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | -12.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 9.88 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.88 |
| Piotroski F-Score | 6 |
